Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunological Responses After Vaccination for COVID-19 With the Messenger Ribonucleic Acid (mRNA) Vaccine Comirnaty in Immunosuppressed and Immunocompetent Individuals. An Open and Non-randomized, Phase IV Multicenter Study

NCT04780659 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT04780659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04780659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunological Responses After Vaccination for COVID-19 With the Messenger Ribonucleic Acid (mRNA) Vaccine Comirnaty in Immunosuppressed and Immunocompetent Individuals. An Open and Non-randomized, Phase IV Multicenter Study
Lead sponsor
Karolinska University Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 23, 2021
Completion date
May 8, 2024
Enrollment
539 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19